EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Risk of Insomnia Disorder in Japanese Cancer Patients: A Matched Cohort Study Using Employer‐Based Health Insurance Claims Data

Risa Murakami iD, Hiroyuki Sato iD, Akihiro Hirakawa iD

Cancer Medicine · 2026-06 · 15 (6)

DOI: 10.1002/cam4.71913 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cancer Medicine, online erschienen am 07.06.2026. Verfasst von Risa Murakami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institution of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insomnia is a common clinical symptom that significantly impairs quality of life (QOL) and it frequently occurs in cancer patients. However, the risk of insomnia in Japanese cancer patients compared with cancer‐free patients has not yet been studied.

Aims

This study evaluated the association between cancer diagnosis and the risk of insomnia disorder in the Japanese health insurance claims database.

Methods

A population‐based matched cohort study was performed comparing cancer patients with cancer‐free patients. The primary outcome was the time to onset of insomnia disorder in cancer and cancer‐free patients. Multivariate analyses were performed to determine hazard ratio (HR) for all patients and for each cancer type.

Results

A total of 36,230 cancer patients and 362,300 cancer‐free patients were enrolled in this study. The median age was 53 years. Among cancer patients, the time to onset of insomnia disorder was significantly shorter than that of cancer‐free patients (stratified log‐rank testing; p < 0.001). In the multivariate analysis, the HR of cancer status (HR 3.39; 95% CI 3.28–3.49) was largest. In the subgroup analysis, the insomnia disorder risk was highest in patients with esophageal cancer, multiple cancers, gallbladder/biliary tract cancer, and bone and articular cartilage cancer.

Conclusions

This study shows that Japanese cancer patients have a higher risk of developing insomnia disorder compared with cancer‐free patients. The risk was especially high in cancer types which have a poor prognosis or impair the QOL of patients. These findings highlight the importance of assessing insomnia disorder frequently in cancer patients and providing interventions when it is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Initiation and Maintenance DisordersNeoplasmsHumansFemaleMiddle AgedMaleJapanAdultAgedRisk FactorsCohort StudiesInsurance, HealthQuality of LifeYoung AdultEast Asian People

Stichwörter der Autor:innen

cancerinsomnianationwide claims databaseoncology

Autor:innen und Institutionen

  • Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institution of Science Tokyo, Tokyo, Japan.

ORCID-Profile: Risa Murakami, Hiroyuki Sato, Akihiro Hirakawa

Zitieren

APA

Murakami, R., Sato, H., & Hirakawa, A. (2026). Risk of Insomnia Disorder in Japanese Cancer Patients: A Matched Cohort Study Using Employer‐Based Health Insurance Claims Data. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.71913

Vancouver

Murakami R, Sato H, Hirakawa A. Risk of Insomnia Disorder in Japanese Cancer Patients: A Matched Cohort Study Using Employer‐Based Health Insurance Claims Data. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.71913

BibTeX
@article{Murakami2026,
  author = {Murakami, Risa and Sato, Hiroyuki and Hirakawa, Akihiro},
  title = {Risk of Insomnia Disorder in Japanese Cancer Patients: A Matched Cohort Study Using Employer‐Based Health Insurance Claims Data},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  doi = {10.1002/cam4.71913}
}
Kostenlos starten →